Excellence Rankings 2022
The Excellence Rankings celebrate the greatest achievements and innovations in the industry. The programme provides a platform to recognise the people and companies that are driving change.
Our programme is designed to highlight excellence within the sector by looking at a range of corporate activities including deals, business projects and company initiatives, both internal and in the community.
What is Diversity?
Diversity is a subject that should be at the forefront of every modern company’s recruitment strategy and should not be considered as simply an exercise in virtue signalling. The more diverse a workforce, the more representative it is of wider society, which brings clear benefits to any corporation attempting to gain greater insight into the views of its customer base. In addition, more diverse companies have greater appeal to candidates in the jobs market, increasing a company’s chances of hiring the best talent.
In this category we consider any internal company project to improve diversity in the workforce, this can include changes to hiring policies; graduate and apprenticeship schemes; work groups and societies; and subconscious bias training. In addition we look at external company policies and practices aimed at making their products and services more accessible and inclusive.
Clinical Trials Arena Excellence Awards & Rankings 2022 – Media PackBy Excellence Awards
Is your company ranked?
If you want to learn more about the Rankings and the range of marketing materials and options available to promote your achievement then please get in touch with us or download the Media Pack:
Contact: Sundeep Makkar – Sundeep.Makkar@Verdict.co.uk
The main source of optimism for diversity in clinical trials is AI. More and more companies are realising how the lack of diversity in clinical trials is holding them back and in response they have been partnering up with specialised tech companies for solutions.
These include primarily offering AI-driven recruitment as a means of diversifying subject pools, but dedicated AI companies can not only diversify clinical trials, they can improve the overall design of a trial, as has been the case with the partnership between ConcertAI and Jenssen.
AI isn’t just important from the standpoint of trial efficiency and diversification. The industry has had to face issues of misinformation and trust with the recent wave of anti vax sentiments just the latest example. In light of this AI is also proving a potential solution to rebuild trust in clinical trials and the scientific process in general.
This category highlights companies that have contributed to the push for more diversity in clinical trials.